CRAVIT OPHTHALMIC SOLUTION 1.5% w/v
INDICATIONS
Susceptible strains of Staphylococcus sp., Streptococcus sp., Streptococcus pneumoniae, Enterococcus sp., Micrococcus sp., Moraxella sp., Corynebacterium sp., Klebsiella sp., Enterobacter sp., Serratia sp., Proteus sp., Haemophilus influenzae, Haemophilus aegyptius [Koch-Weeks bacillus], Pseudomonas sp., Pseudomonas aeruginosa, Acinetobacter sp., and Propionibacterium acnes.
Blepharitis, dacryocystitis, hordeolum, conjunctivitis, tarsadenitis, keratitis (including corneal ulcer), and postoperative infections.
- In order to avoid the emergence of resistant bacteria, bacterial susceptibility should be confirmed and treatment with this drug should be limited to the minimum period required for the eradication of the infection.
- The efficacy of this product to methicillin-resistant Staphylococcus aureus (MRSA) has not been proven. Therefore, other drug having a potent anti-MRSA activity should be administered immediately to patients positively infected with MRSA and not showing any improvement of symptoms with this product.
CONTRAINDICATIONS (This product is contraindicated in the following patients.)
Patients with a history of hypersensitivity to the ingredient of this product, ofloxacin or any quinolone antibiotics.
DOSAGE AND ADMINISTRATION
Usually, instill 1 drop a time to the eye 3 times daily. The dosage may be adjusted according to the patient’s symptoms.
